ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.779,54
-0,58%
S&P 500
5.306,04
0,02%
US Dollar vs BRL
5,1631
-0,20%
Bitcoin
68.371,98
-1,47%
Brent Oil
84,325
1,79%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sight Sciences Inc (SGHT)

  7. Sight Sciences Inc (SGHT) Notícias

SGHT

Sight Sciences (SGHT)

Sight Sciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SGHT
DataHoraFonteTítuloCódigoCompanhia
28/05/202417:05GlobeNewswire Inc.Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from RestasisNASDAQ:SGHTSight Sciences Inc
28/05/202409:30GlobeNewswire Inc.Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced GlaucomaNASDAQ:SGHTSight Sciences Inc
20/05/202421:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/05/202417:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SGHTSight Sciences Inc
07/05/202417:05GlobeNewswire Inc.Sight Sciences to Present at the Upcoming Bank of America Healthcare ConferenceNASDAQ:SGHTSight Sciences Inc
06/05/202417:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SGHTSight Sciences Inc
02/05/202417:05GlobeNewswire Inc.Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial GuidanceNASDAQ:SGHTSight Sciences Inc
29/04/202409:05GlobeNewswire Inc.Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma SurgeryNASDAQ:SGHTSight Sciences Inc
18/04/202417:05GlobeNewswire Inc.Sight Sciences to Report First Quarter Financial Results on May 2, 2024NASDAQ:SGHTSight Sciences Inc
10/04/202417:05GlobeNewswire Inc.Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2NASDAQ:SGHTSight Sciences Inc
02/04/202417:05GlobeNewswire Inc.Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual MeetingNASDAQ:SGHTSight Sciences Inc
26/03/202417:05GlobeNewswire Inc.Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare ConferenceNASDAQ:SGHTSight Sciences Inc
07/03/202418:05GlobeNewswire Inc.Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial GuidanceNASDAQ:SGHTSight Sciences Inc
22/02/202418:05GlobeNewswire Inc.Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024NASDAQ:SGHTSight Sciences Inc
14/02/202419:24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SGHTSight Sciences Inc
14/02/202418:05GlobeNewswire Inc.Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter MeetingNASDAQ:SGHTSight Sciences Inc
07/02/202417:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGHTSight Sciences Inc
02/02/202418:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGHTSight Sciences Inc
23/01/202418:05GlobeNewswire Inc.Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules CapitalNASDAQ:SGHTSight Sciences Inc
08/01/202418:05GlobeNewswire Inc.Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial HighlightsNASDAQ:SGHTSight Sciences Inc
28/12/202311:15GlobeNewswire Inc.Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative ContractorsNASDAQ:SGHTSight Sciences Inc
18/12/202318:05GlobeNewswire Inc.Sight Sciences Announces the Publication of Successful Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye DiseaseNASDAQ:SGHTSight Sciences Inc
08/12/202310:05GlobeNewswire Inc.Sight Sciences Announces the Acceptance for Publication of GEMINI 2, a Three Year, Prospective, Multicenter Trial Demonstrating Sustained, Significant IOP and Medication Reductions Enabled with the OMNI® Surgical System TechnologyNASDAQ:SGHTSight Sciences Inc
01/12/202318:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SGHTSight Sciences Inc
16/11/202319:35Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SGHTSight Sciences Inc
07/11/202318:05GlobeNewswire Inc.Sight Sciences Reports Third Quarter 2023 Financial Results and Withdraws Guidance for Full Year 2023NASDAQ:SGHTSight Sciences Inc
24/10/202317:05GlobeNewswire Inc.Sight Sciences to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:SGHTSight Sciences Inc
19/10/202317:05GlobeNewswire Inc.Sight Sciences to Host SAHARA 6 Month RCT Results Reception at the American Academy of Ophthalmology 2023NASDAQ:SGHTSight Sciences Inc
12/10/202317:05GlobeNewswire Inc.Sight Sciences Announces Presentation of Successful Phase I Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease at the American Academy of Optometry Annual MeetingNASDAQ:SGHTSight Sciences Inc
03/10/202309:30GlobeNewswire Inc.Sight Sciences Announces New, Large-Scale MIGS Data from 41st Congress of ESCRS Demonstrating TCOR™ Using OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with GlaucomaNASDAQ:SGHTSight Sciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SGHT

Seu Histórico Recente

COIN
TYUST
Takyon
CSE
YY
Yellow Stem Tech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados